Real-world therapy with pembrolizumab: outcomes and surrogate endpoints for predicting survival in advanced melanoma patients in Germany - Mohr, Peter; Scherrer, Emilie; Assaf, Chalid; Bender, Marc; Berking, Carola; Chandwani, Sheenu; Eigentler, Thomas; Grimmelmann, Imke; Gutzmer, Ralf; Haferkamp, Sebastian; Hassel, Jessica C.; Hauschild, Axel; et al. (Cancers, 2022)
Gesehen am 18.05.2022